학술논문
Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050.
Document Type
Journal Article
Author
Source
Subject
*TYPE 2 diabetes
*GLUCAGON-like peptide-1 agonists
*SITAGLIPTIN
*DIABETES
*GLYCEMIC index
*
*
*
*
Language
ISSN
0149-5992
Abstract
A correction is presented to the article "Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial." which appeared in March, 2019 issue.